5^th International Conference on Cardiovascular Diseases and Therapeutics September 15-15, 2022 Paris, France

Tracks / Sessions:

Track 01: Interventional Cardiology and Heart Surgery

Interventional cardiology is the subspecialty of cardiology that uses specific catheter-based systems to diagnose and treat coronary artery disease, vascular disease, structural heart disease, and congenital heart defects.

Cardiac surgery is surgery on the heart or great vessels implemented by cardiac surgeons. It is often used to treat difficulties of ischemic heart disease (for example, with coronary artery bypass grafting) or to treat valvular heart disease from various causes. Cardiac surgeons, interventional cardiologists and imaging specialists classically work together as the Heart Team, in particular in structural heart centers of brilliance. In this segment, you will find a selection of content in the field of interventional cardiovascular surgery.

Track 02: Pediatric and Neonatal Cardiology

Pediatric cardiologists stipulate in analyzing and treating heart problems in children. In those children who might want heart surgery, pediatric cardiologists work thoroughly with pediatric heart surgeons to regulate the best treatments and interventions. A number of heart disorders can affect children. Some are structural consistencies they are born with.

Neonatal cardiology is the valuation and management of full-term and premature newborns with heart defects.

Track 03: Hypertension and Healthcare

Blood pressure is the force smeared by circulating blood against the walls of the body’s arteries, the major blood vessels in the body. Hypertension is when blood pressure is too high. Blood pressure is inscribed as two numbers. The first (systolic) number signifies the density in blood vessels when the heart contracts or beats. The second (diastolic) number signifies the density in the vessels when the heart rests between beats.

Healthcare is the care or improvement of health via the hindrance, diagnosis, treatment, amelioration, or cure of disease, illness, injury, and other physical and mental impairments in people. Health care is carried by health professionals and allied health fields. Medicine, dentistry, pharmacy, midwifery, nursing, optometry, audiology, psychology, occupational therapy, physical therapy, athletic training, and other health professions are all part of health care. It embraces work done in providing primary care, secondary care, and tertiary care, as well as in public health.

Track 04: Heart Rhythm and Arrhythmia

A heart arrhythmia (uh-RITH-me-uh) is an irregular heartbeat. Heart rhythm problems (heart arrhythmias) occur when the electrical signals that manage the heart's beats don't work appropriately. The faulty signaling sources the heart to beat too fast (tachycardia), too slow (bradycardia) or irregularly. Heart arrhythmias may feel like a beating or racing heart and may be inoffensive. However, some heart arrhythmias may cause bothersome.

In a usual heart rhythm, a tiny mass of cells at the sinus node sends out an electrical signal. The signal then investigations through the atria to the Atrioventricular (AV) node and into the ventricles, causing them to indenture and pump blood. A heart arrhythmia (uh-RITH-me-uh) is an uneven heartbeat.

Track 05: Heart Failure and Cardiomyopathies

Cardiomyopathy is an ailment of the heart muscle that makes it harder for your heart to pump blood to the rest of your body. Cardiomyopathy can lead to heart failure.

The main kinds of cardiomyopathy comprise dilated, hypertrophic and restrictive cardiomyopathy. Treatment — which might embrace medications, surgically implanted devices, heart surgery or, in severe cases, a heart transplant — depends on which type of cardiomyopathy you have and how serious it is.

Track 06: Acute Coronary Syndromes

The stint acute coronary syndrome (ACS) is applied to patients in whom there is a suspicion or confirmation of acute myocardial ischemia or infarction. Non-ST-elevation myocardial infarction (NSTEMI), ST-elevation MI (STEMI), and uneven angina are the three traditional sorts of ACS. However, the widespread use of the high-sensitivity troponin test has altered the diagnosis of unstable angina to NSTEMI in almost all patients formerly analyzed with unstable angina. This has happened because those patients formerly called unstable angina actually have unusually elevated high-sensitivity troponin values.

Track 07: Robotic Heart Surgery

Robotic cardiac surgery is heart surgery done through very minor cuts in the chest. With the use of tiny instruments and robot-controlled tools, surgeons are capable to do heart surgery in a way that is ample less invasive than open-heart surgery. The procedure is sometimes called da Vinci surgery because that is the name of the manufacturer of the robot often used for this technique. Robotic surgeries have been used for a number of dissimilar heart-related procedures, including valve surgery, coronary artery bypass, cardiac tissue ablation, heart defect repair, and tumor removal.

Track 08: Cardiac Imaging

Cardiac imaging states to non-invasive imaging of the heart using ultrasound, magnetic resonance imaging (MRI), computed tomography (CT), or nuclear medicine (NM) imaging with PET or SPECT. These cardiac procedures are otherwise stated to as echocardiography, Cardiac MRI, Cardiac CT, Cardiac PET and Cardiac SPECT including myocardial perfusion imaging.

Track 09: Cardio-Oncology

Cardio oncology or cardiovascular oncology is an interdisciplinary arena of medicine by which are considered the molecular and clinical alterations in cardiovascular system during the different methods of treatment of cancer, especially chemotherapy and targeted therapy. Cardio-oncology is a new field in cardiology. Cardio-oncologists are characteristically cardiologists who see cancer survivors or patients getting cancer treatment who grow side effects that affect the heart. Cardio-oncologists have a special attention in and information about cardiac side effects of chemotherapy, targeted therapy and radiation to treat cancer. Since it is a fairly new arena in cardiology, many U.S. cities do not yet have cardio-oncologists.

Track 10: Echocardiography

An echocardiography, cardiac echo or simply an echo is an ultrasound of the heart. It is a kind of medical imaging of the heart, using standard ultrasound or Doppler ultrasound. Echocardiography has turn out to be routinely used in the diagnosis, management, and follow-up of patients with any alleged or known heart diseases. It is one of the most extensively used diagnostic tests in cardiology. It can offer a wealth of helpful information, comprising the size and shape of the heart (internal chamber size quantification), pumping capacity, and the location and extent of any tissue damage. An echocardiogram can also give physicians other estimations of heart function, such as a control of the cardiac output, ejection fraction, and diastolic function (how well the heart relaxes).

Track 10: Coronary Heart Diseases

Coronary Artery Disease (CAD), or coronary heart disease, progresses when the coronary arteries become too narrow or cholesterol blockages develop in the walls. The coronary arteries are the blood vessels that source oxygen and blood to the heart. CAD inclines to improve when cholesterol builds up on the artery walls, creating plaques. These plaques affect the arteries to narrow, reducing blood flow to the heart, or can root inflammation in and hardening of the walls of the blood vessel. A clot can occasionally obstruct blood flow, causing solemn health problems.

Track 11: Cardiac Regeneration

Cardiac regeneration is a wide exertion that matters to repair irreversibly injured heart tissue with cutting-edge science, with stem cell and cell-free therapy. Reparative tools have been engineered to renew damaged heart tissue and purpose by the body's natural ability to regenerate. Working together, patients and providers are finding regenerative solutions that reinstate, renew and recycle patients' own reparative capacity. Through the vision and generous provision of Russ and Kathy Van Cleve, strong exertions are underway to cultivate discoveries that will have a global influence on ischemic heart disease.

Track 12: Cardiac Nursing: Acute and Chronic Cardiac Care

Cardiac nursing is a nursing field that works with patients who suffer from various situations of the cardiovascular system. Cardiac nurses aid treat conditions such as unstable angina, cardiomyopathy, coronary artery disease, congestive heart failure, myocardial infarction and cardiac dysrhythmia under the way of a cardiologist.

Cardiac nurses accomplish postoperative care on a surgical unit, stress test evaluations, cardiac monitoring, vascular monitoring, and health assessments. Cardiac nurses must have Basic Life Care and Advanced Cardiac Life Support certification. In addition, cardiac nurses must own specialized skills counting electrocardiogram monitoring, defibrillation, and medication management by continuous intravenous drip. Cardiac nurses work in numerous different environments, including coronary care units (CCU), cardiac catheterization, intensive care units (ICU), operating theatres, cardiac rehabilitation centers, clinical research, cardiac surgery wards, cardiovascular intensive care units (CVICU), and cardiac medical wards.

Track 13: Cardiac Pharmacology

The advent of drugs bright to modulate the renin–angiotensin system (RAS), and more recently the neprilysin inhibitor sacubitril in mixture with a RAS blocker, has better the outcome of many cardiovascular and renal conditions. In specific, heart failure, post-myocardial infarction, and hypertension are the cardiovascular clinical syndromes in which RAS inhibition (and in heart failure, in combination with neprilysin inhibition) have significantly improved morbidity and mortality. This section aims to offer an appraisal of RAS and neprilysin inhibitors concerning their pharmacological properties with respect to mechanism(s) of action, pharmacokinetics, monitoring, adverse effects, and drug interactions.

Track 14: Nuclear Cardiology

Nuclear cardiology studies use noninvasive methods to assess myocardial blood flow, appraise the pumping function of the heart as well as imagine the size and position of a heart attack. Among the methods of nuclear cardiology, myocardial perfusion imaging is the most widely used.

Market Analysis:

The overall coronary artery disease therapeutics market is anticipated to magnify in the near future. This is because of a surge in the claim of this therapeutics owing to the rising incidences of chronic disease across the world. Coronary Artery Disease Therapeutics is procedure which includes several techniques such as stem cells, nanotechnology and robotic surgery for the efficient treatment of Coronary Artery Disease.

The global coronary artery disease market is categorized based on treatment and test. Based on behavior, the market is segmented into drugs, surgery, cardiac rehabilitation, and angioplasty. Among all of them, drug segment is probable to hold largest market share in the global coronary artery disease market in the near future. On the basis of test, the worldwide coronary artery disease therapeutics market is segmented into Cardiac catheterization test, Cardiac CT scan, Coronary angiography, and Electrocardiogram.

A recently propelled report on the global coronary artery disease therapeutics market by TMR will aid readers with qualitative and quantitative analysis of the market. The report entails of all the crucial drivers, restraints, challenges and opportunities of the global coronary artery disease therapeutics market. The authors of the report scope to several market leaders and key players in order to add credibility into the global coronary artery disease therapeutics market. Apart from this, the report designates various segments, regional outlook and competitive landscape of the global coronary artery disease market. This will aid readers have a well outlook on the pivotal aspect of the market during the forecast period 2018- 2026.

Global Coronary Artery Disease Therapeutics Market: Market Potential and Key Trends

The analysts assume a steady growth of the coronary artery disease therapeutics market in the near future. This is because prolonged presence of coronary arterial diseases could lead to serious consequences. Apart from this, cumulative adoption of coronary artery disease therapeutics by patients. This awakening amongst people is also a vital factor to bolster the market.  Moreover, changing lifestyles and unsuitable eating habits are some other factors fueling the development of the global coronary artery disease therapeutics market

Despite numerous drivers, high cost of therapeutics, limited cognizance and unavailability of proper healthcare infrastructure for the therapeutics in expected to restraint the growth of the global coronary artery disease therapeutics market in the coming years. However, the increasing investment on research and development activity of coronary artery disease therapeutics is a strong factor likely to overcome these factors in the future.

Global Coronary Artery Disease Therapeutics Market: Geographical Outlook

On the source of geography, the universal coronary artery disease therapeutics market can be segmented into North America, Latin America, Europe, Asia Pacific, and the Middle East & Africa. Amongst all of them, North America is expected to dominate the global coronary artery disease therapeutics market in the forecast years. This is because of the aggregate incidence of traumatic cardiac disorder, growing geriatric population and the occurrence of a large number of key players in the region.

Global Coronary Artery Disease Therapeutics Market: Competitive Landscape

Key players functioning in the global coronary artery disease therapeutics market are converging on technological innovation to launch advanced products. This will aid them increase their market grasp in the future years.  Some of the key players working in the global coronary artery disease therapeutics market are Gilead, AstraZeneca, Lupine Pharmaceuticals Inc., Novartis, Abbott Vascular, and Pfizer Inc.

This study by TMR is all-encompassing framework of the dynamics of the market. It frequently encompasses critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.

Cardiology Market in Asia-Pacific:

The Asia Pacific interventional cardiology market is predictable to increase at a 7.9 percent CAGR from 2017 to 2023. Cardiac monitoring and diagnostic market size in Asia is 4.5 billion USD in 2015, rising to 6 billion USD in 2017 with an 8% growth rate, and expected to reach 12 billion USD by 2023.

Rendering to the International Diabetes Federation, Asia is home to 60% of the world's diabetes population. Diabetes is one of the foremost causes of cardiovascular disease. The rising prevalence of cardiovascular ailments is the primary driver of market growth in Asia Pacific. Aside from the rising prevalence of diabetes and obesity, changes in lifestyle, more public awareness, and quick technological advancements all subsidized to the market's expansion. On the other hand, high cost for manufacturing the devices and a lot of barriers for the course of the new device are the main limitations hampering the market growth.

CVDT 2021:

We gratefully express thank all our pleasing speakers, conference attendees, students for making CVDT 2021 Conference the best ever!

The “3rd International Conference on Cardiovascular Diseases and Therapeutics” was held during April 01-02, 2020 in Amsterdam, Netherlands. The generous response was received from the Editorial Board Members of Journals along with scientists, researchers, students, and leaders from various fields of Cardio Vascular Diseases, who made this event a grand success. We are acknowledging with gratitude and support by all the Editorial Board Members of “Cardiovascular Diseases & Diagnosis” for their valuable suggestions for the growth of the Organization.

The conference was initiated with the Honorable presence of the Keynote forum. The heartfelt gratitude to the Organizing Committee Associates, many external experts, company representatives and other eminent personalities who supported the conference by facilitating the discussion forums. We also took the privilege to felicitate the Organizing Committee Members, Editorial Board Members and Media Partners who supported this event.

By the outstanding accomplishment of CVDT 2021, it is proud to announce the “5th International Conference on Cardiovascular Diseases and Therapeutics” to be held during July 13-14, 2022 in Australia. CVDT 2022 has been organized with the intention and the specific intent of promoting the development of new perspectives and ideas for exploiting the high level of Awareness attained by the scientific community in various Cardio Vascular Disease fields.

Let us meet at @ CVDT 2022